Biotech & Bioprocessing

New York State Enhances Measures to Address Avian Influenza Concerns
Biotech & Bioprocessing New York State Enhances Measures to Address Avian Influenza Concerns

New York State is actively taking proactive steps to prevent and manage Highly Pathogenic Avian Influenza (HPAI) through heightened monitoring and encouraged testing. This initiative aims at early detection to combat the virus, especially given recent HPAI cases recorded in the wild bird population

McMaster and Sartorius Launch Bioprocessing Automation Lab
Biotech & Bioprocessing McMaster and Sartorius Launch Bioprocessing Automation Lab

In a remarkable advancement for the field of biotechnology, McMaster University and Sartorius have inaugurated a state-of-the-art bioprocessing automation laboratory at the university’s Faculty of Engineering, setting a new standard for bioprocess modeling, simulation, and advanced control. This c

How Will Regenerative Medicine Transform Health Care by 2030?
Biotech & Bioprocessing How Will Regenerative Medicine Transform Health Care by 2030?

The field of regenerative medicine is poised to revolutionize healthcare by 2030. With rapid advancements in stem cell therapy, gene therapy, and tissue engineering, this innovative sector offers groundbreaking treatments for a wide array of health conditions. From chronic diseases to injuries and

Is Sanofi's Framingham Facility Falling Short of FDA Standards?
Biotech & Bioprocessing Is Sanofi's Framingham Facility Falling Short of FDA Standards?

The US Food and Drug Administration (FDA) raised serious concerns about Sanofi's manufacturing facility in Framingham, Massachusetts, by issuing a Warning Letter for significant deviations from current Good Manufacturing Practice (cGMP) standards for drug substance production. This alarming

How Can We Increase Biosecurity to Shield Birds from Avian Influenza?
Biotech & Bioprocessing How Can We Increase Biosecurity to Shield Birds from Avian Influenza?

The rise of avian influenza presents a significant threat to both domestic and wild bird populations, making it imperative to adopt robust biosecurity measures to prevent its spread. This issue is increasingly pressing, especially considering recent reports of bird flu virus detections in various

Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge
Biotech & Bioprocessing Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge

In an optimistic outlook at the 43rd JPM Conference in San Francisco, Thermo Fisher CEO Marc Casper underscored the firm's strategic adaptations and growth initiatives tailored to meet surging demand for GLP-1 diabetes and weight loss products. Thermo Fisher Scientific's extensive

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later